The emergence of new biotechnologies, especially gene drives, genome editing and RNAi technologies, which result in a broader range of applications and which, by extension, help governments to attain a broader range of policy goals, has also resulted in increased requests for support.
In addition to its previous work concerning the regulation of genetically modified organisms (GMOs), the ICGEB is expanding the type of assistance it provides; to include, for example, the exploration and refinement of the regulatory arenas that cover non-GMO biotechnology products.
For this reason the “Biosafety Group” has recently been renamed the “Regulatory Science Group” to reflect the widening of its activities.
For more information, please visit: https://www.icgeb.org/regulatory-science.